Observational studyEuropean geriatric medicine2025
Potentially inappropriate medication use by TIME criteria in nursing home residents and its relationship with common geriatric syndromes.
Observational study in European geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess potentially inappropriate medication use (IMU), including both potentially inappropriate prescribing (PIP) and potential prescribing omissions (PPOs) according to the Turkish Inappropriate Medication Use in oldEr adults (TIME) criteria in older nursing home residents and to investigate its association with common geriatric syndromes.
methodsThis multi-center cross-sectional observational study was conducted from December 2023 to June 2024 across three nursing homes in Istanbul. Two geriatricians performed comprehensive geriatric assessments and used TIME criteria to identify IMU. The link between prevalent geriatric syndromes and IMU was examined.
resultsWe included 165 residents with a mean age of 84.6 ± 7.9 years, 71.5% of whom were female. Of the participants, 81.6% (n = 134) had dementia. Respectively, 93% (n = 154) and 51% (n = 85) of the participants had polypharmacy and hyperpolypharmacy. The top three PIPs according to TIME-to-STOP criteria were tight blood pressure control with antihypertensives (51.5%), use of neuroleptics as hypnotics(50.3%), and proton pump inhibitors (PPIs) for multiple drug use indication (47.3%).Based on the TIME-to-START criteria, the three most common PPOs were the omission of acetylcholinesterase inhibitors for mild-moderate Alzheimer's disease and memantine for moderate-severe Alzheimer's disease and failure to initiate oral nutritional supplements in malnourished or at-risk individuals(47.9%).TIME-to-STOP PIPs were significantly associated with polypharmacy (p < 0.001) in univariate analysis. In the logistic regression analyses of variables associated with TIME-to-START PPO, significant associations were observed with age (odds ratio (OR) = 1.14; 95% confidence interval (CI): 1.02-1.27; p = 0.015) and frailty (OR: 2.95; 95% CI: 1.209-7.201; p = 0.017), the latter conferring a roughly threefold increased risk.
conclusionPolypharmacy and IMU were highly prevalent among nursing home residents, and national/international prescribing tools like the TIME criteria are valuable in detecting both PIPs and PPOs. Frailty was significantly associated with prescribing omissions as identified by the TIME-to-START criteria, underscoring the need for targeted interventions in this vulnerable population.
Indexed as
Identifiers
41175186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.